1
|
Silva L, Al-Oraibi A, Nanakali S, Gogoi M, Hassan O, Al-Sharabi I, Sahare P, Pareek M, Qureshi I, Nellums LB. Experiences of antibiotic use and healthcare access among migrants to the UK: a qualitative study. BMC Public Health 2025; 25:1794. [PMID: 40375083 DOI: 10.1186/s12889-025-22384-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2023] [Accepted: 03/19/2025] [Indexed: 05/18/2025] Open
Abstract
BACKGROUND In recent years, migration to and within Europe has increased. Human mobility has been hypothesised as a contributing factor towards antimicrobial resistance (AMR). However, there is limited evidence to explain how migration contributes towards antibiotic resistance. More qualitative research regarding migrants' perspectives of antibiotic use is needed to understand this complex interaction. The aim of this study was to explore experiences of antibiotic use and healthcare access among migrants in the UK, and how this might influence the risk of AMR. METHODS Adult migrants were purposively recruited through community organisations, collaborators, online platforms and snowball sampling representing different migrant statuses, countries of origin and ethnicities. Semi-structured interviews were conducted online, by phone or face-to-face, in participants' preferred languages, between March and July 2022 exploring antibiotic use and healthcare access. Data were analysed thematically and the study was informed by a Project Advisory Committee, with members from Doctors of the World and professionals who were previously refugees or asylum seekers. RESULTS Twenty-seven migrants (17 males and 10 females), aged 21-60, from 17 different countries were interviewed. Four main themes were generated: 1) Uncharted territory: navigating a new healthcare system (sub-themes (a) access to care during journey, (b) difficult access to healthcare in the UK and (c) comparison between different healthcare systems); 2) Preserving the sense of agency and decision-making around antibiotic use, 3) Self-perpetuating cycle (sub-themes - (a) co-infections; (b) using alarming symptoms or "red-flags" and (c) taking antibiotics due to previous similar symptoms or persisting symptoms), and 4) The fragile state of the patient-doctor relationship. CONCLUSIONS These findings give useful insight into barriers faced by migrants when trying to access healthcare services both en route and after arriving in the UK, as well as their attitudes and behaviours in relation to antibiotics. Results also shed light on the complexity of factors contributing to health-seeking behaviour and antibiotic use, and how these may vary depending on previous experiences. We discuss implications for future research and practice, and how current policies may need to evolve to better support and reduce possible risk factors for AMR in migrant communities.
Collapse
Affiliation(s)
- Luisa Silva
- Lifeorgdivision and Population Health, School of Medicine, University of Nottingham, Nottingham, UK
- Department of Respiratory Sciences, University of Leicester, Leicester, UK
- Development Centre for Population Health, University of Leicester, Leicester, UK
| | - Amani Al-Oraibi
- Lifeorgdivision and Population Health, School of Medicine, University of Nottingham, Nottingham, UK
- Department of Respiratory Sciences, University of Leicester, Leicester, UK
- Development Centre for Population Health, University of Leicester, Leicester, UK
| | - Shajwan Nanakali
- Lifeorgdivision and Population Health, School of Medicine, University of Nottingham, Nottingham, UK
- Pharmacy Department, Tishk International University, Erbil, Iraq
| | - Mayuri Gogoi
- Department of Respiratory Sciences, University of Leicester, Leicester, UK
- Development Centre for Population Health, University of Leicester, Leicester, UK
| | - Osama Hassan
- Lifeorgdivision and Population Health, School of Medicine, University of Nottingham, Nottingham, UK
| | | | - Pankhuri Sahare
- Lifeorgdivision and Population Health, School of Medicine, University of Nottingham, Nottingham, UK
| | - Manish Pareek
- Department of Respiratory Sciences, University of Leicester, Leicester, UK
- Development Centre for Population Health, University of Leicester, Leicester, UK
| | - Irtiza Qureshi
- Lifeorgdivision and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.
- Development Centre for Population Health, University of Leicester, Leicester, UK.
- Centre for Public Health and Epidemiology, University of Nottingham, Nottingham, UK.
- Centre for Inequalities, Institute for Lifecourse Development, University of Greenwich, London, UK.
| | - Laura B Nellums
- Lifeorgdivision and Population Health, School of Medicine, University of Nottingham, Nottingham, UK
- College of Population Health, Health Sciences Center, University of New Mexico, Albuquerque, NM, USA
| |
Collapse
|
2
|
Cotugno S, De Vita E, Frallonardo L, Novara R, Papagni R, Asaduzzaman M, Segala FV, Veronese N, Nicastri E, Morea A, Farkas FB, Lakatos B, Iatta R, Putoto G, Saracino A, Di Gennaro F. Antimicrobial Resistance and Migration: Interrelation Between Two Hot Topics in Global Health. Ann Glob Health 2025; 91:12. [PMID: 40061583 PMCID: PMC11887466 DOI: 10.5334/aogh.4628] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2024] [Accepted: 02/01/2025] [Indexed: 05/13/2025] Open
Abstract
Background: Antimicrobial resistance (AMR) and migration are two interlinked issues and both pose an escalating threat to global health. With an increasing trend, there are 281 million migrants globally, while AMR is contributing to over 5 million deaths annually, with a projected rise to 10 million by 2050 if left unaddressed. Both AMR and migration are multifaceted problems that extend beyond human health, involving animals, plants, and the environment-a fact highlighted by the One Health approach. Objective: The aim of this work is: (1) to examine the complex relationship between migration and AMR, drawing on epidemiological data, surveillance strategies, and healthcare access challenges and (2) to address an interventional strategy proposal. Methods: We performed a narrative review of the most updated literature about migration and AMR using three primary databases: PubMed, Scopus, and Embase. Findings: Migrants, particularly from low‑ and middle‑income countries, represent a unique group at increased risk of AMR due to factors such as overcrowded living conditions, limited access to healthcare, uncontrolled use of antibiotics, and high prevalence of AMR in origin countries. Studies reveal higher rates of AMR colonization and infection among migrants compared with native populations, with specific pathogens such as MRSA and multidrug‑resistant gram‑negative bacteria posing significant risks. Migratory conditions, socioeconomic vulnerability, and healthcare barriers contribute to this heightened risk. Conclusion: To address the intersection of migration and AMR, interventions must focus on improving living conditions, enhancing healthcare access, promoting appropriate antibiotic use, and strengthening microbiological surveillance. Multisectoral collaboration is essential to mitigate the spread of AMR and safeguard both migrant and global public health.
Collapse
Affiliation(s)
- Sergio Cotugno
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‑J), Unit of Infectious Diseases, University of Bari ‘A. Moro’, Polyclinic Hospital, Bari, Italy
| | - Elda De Vita
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‑J), Unit of Infectious Diseases, University of Bari ‘A. Moro’, Polyclinic Hospital, Bari, Italy
| | - Luisa Frallonardo
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‑J), Unit of Infectious Diseases, University of Bari ‘A. Moro’, Polyclinic Hospital, Bari, Italy
| | - Roberta Novara
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‑J), Unit of Infectious Diseases, University of Bari ‘A. Moro’, Polyclinic Hospital, Bari, Italy
| | - Roberta Papagni
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‑J), Unit of Infectious Diseases, University of Bari ‘A. Moro’, Polyclinic Hospital, Bari, Italy
| | - Muhammad Asaduzzaman
- Department of Community Medicine and Global Health, Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Francesco Vladimiro Segala
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‑J), Unit of Infectious Diseases, University of Bari ‘A. Moro’, Polyclinic Hospital, Bari, Italy
| | - Nicola Veronese
- Saint Camillus International University of Health Sciences, Rome, Italy
| | - Emanuele Nicastri
- Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, 00149, Rome, Italy
| | - Anna Morea
- Interdisciplinary Department of Medicine, University of Bari, Bari, Italy
| | - Ferenc Balázs Farkas
- Institute of Medical Microbiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary; Pediatric Center, Semmelweis University, Budapest, Hungary
| | - Botond Lakatos
- Semmelweis University Department of Internal Medicine and Hematology, Departmental Group of Infectious Diseases, Budapest, Hungary
| | - Roberta Iatta
- Interdisciplinary Department of Medicine, University of Bari, Bari, Italy
| | - Giovanni Putoto
- Operational Research Unit, Doctors with Africa CUAMM, Padova, Italy
| | - Annalisa Saracino
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‑J), Unit of Infectious Diseases, University of Bari ‘A. Moro’, Polyclinic Hospital, Bari, Italy
| | - Francesco Di Gennaro
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‑J), Unit of Infectious Diseases, University of Bari ‘A. Moro’, Polyclinic Hospital, Bari, Italy
| |
Collapse
|
3
|
Aljadeeah S, Payedimarri AB, Kielmann K, Michielsen J, Wirtz VJ, Ravinetto R. Access to medicines among asylum seekers, refugees and undocumented migrants across the migratory cycle in Europe: a scoping review. BMJ Glob Health 2024; 9:e015790. [PMID: 39414330 PMCID: PMC11481121 DOI: 10.1136/bmjgh-2024-015790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2024] [Accepted: 09/26/2024] [Indexed: 10/18/2024] Open
Abstract
INTRODUCTION Access to essential medicines is a critical element of health systems and an important measure of their performance. Migrants may face barriers in accessing healthcare, including essential medicines, throughout the migration cycle, which includes the stages of departure from home or residence countries, transit through non-European or European countries, reception and settlement in a country in Europe and deportation. We aim to provide an overview of research and grey literature concerning access to essential medicines for asylum seekers, refugees and undocumented migrants in or heading to Europe (European Union, European Economic Area, Switzerland and the UK). METHODS To delineate and conceptualise access to medicines, we considered the definition of the Lancet Commission on Essential Medicines and the Pharmaceutical Management framework. These frameworks were combined to guide several critical steps in our review, including defining the search terms, data extraction, data analyses and reporting. Relevant studies and reports were identified through searches in bibliographic and grey literature databases. RESULTS Out of 5760 studies and 66 grey literature reports, 108 met the inclusion criteria, with 72 focusing on medicine access. Overall, medicine use and medicine expenditure were found to be lower in migrant populations compared with the host population in many European countries. Although many studies focused on the use of infectious disease and psychotropic medicines, the most frequently used medicines by migrants were analgesics, hypertension and diabetes medicines. Determinants of medicine access were legal restrictions, language and transit times, which all contributed to interruption of and inequities in access to medicines among this population. This scoping review also indicated significant gaps in the literature regarding the evidence on access to medicine at different stages of the migration cycle, specifically in departure, transit and deportation stages. CONCLUSION Overall, our findings highlighted significant unmet medicine needs among migrants in or on the way to Europe and access disparities attributable to various interconnected barriers. Urgent access is needed to address such inequities, particularly legal barriers, including registration of certain medicines required for treatment. Future research should prioritise investigating medicine access during departure, transit and deportation stages. Policy discussions around migrants' access to medicines should be centred on framing healthcare as a fundamental right.
Collapse
Affiliation(s)
- Saleh Aljadeeah
- Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
| | - Anil Babu Payedimarri
- Division of Public Health, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
| | - Karina Kielmann
- Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
| | - Joris Michielsen
- Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
| | - Veronika J Wirtz
- Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA
| | - Raffaella Ravinetto
- Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
- School of Public Health, University of the Western Cape, Cape Town, South Africa
| |
Collapse
|
4
|
Nanakali SS, Hassan O, Silva L, Al‐Oraibi A, Chaloner J, Gogoi M, Qureshi I, Sahare P, Pareek M, Chattopadhyay K, Nellums LB. Migrants' living conditions, perceived health needs and implications for the use of antibiotics and antimicrobial resistance in the United Kingdom: A qualitative study. Health Sci Rep 2023; 6:e1655. [PMID: 37885468 PMCID: PMC10599099 DOI: 10.1002/hsr2.1655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2023] [Revised: 10/05/2023] [Accepted: 10/11/2023] [Indexed: 10/28/2023] Open
Abstract
Background and Aims Antimicrobial resistance (AMR) is among the top public health concerns around the globe. Migrants, especially forced migrants, could be at higher risk of acquiring and transmitting AMR during their journeys or in host countries. There is limited understanding regarding migrants' living conditions and the wider factors contributing to their risk of acquiring infections, and behaviors around antimicrobial use, and AMR development. In this study, we aimed to explore transit experiences, living conditions, and antibiotic use of migrants living in the United Kingdom. Methods We conducted semistructured qualitative interviews with 27 participants and identified five themes regarding migrants' journey and their living conditions during transit and after arriving in the United Kingdom, their access to water, sanitation and hygiene (WASH), and their use of antibiotics. Results Migrants, particularly forced migrants, experienced unfavorable living conditions, poor access to WASH, and challenges in accessing healthcare, which further contributed to health conditions like urinary and skin problems. Isolation and difficulty in accessing healthcare played significant roles in migrants' perceived need for storing and using antibiotics as a safety net. Conclusion The findings highlight the need for coordinated and multilevel interventions to address these challenges and contribute toward tackling AMR and improving the health of this population group.
Collapse
Affiliation(s)
- Shajwan S. Nanakali
- Lifespan and Population Health Academic Unit, School of Medicine, Nottingham City HospitalUniversity of NottinghamNottinghamUK
| | - Osama Hassan
- Lifespan and Population Health Academic Unit, School of Medicine, Nottingham City HospitalUniversity of NottinghamNottinghamUK
| | - Luisa Silva
- Lifespan and Population Health Academic Unit, School of Medicine, Nottingham City HospitalUniversity of NottinghamNottinghamUK
| | - Amani Al‐Oraibi
- Lifespan and Population Health Academic Unit, School of Medicine, Nottingham City HospitalUniversity of NottinghamNottinghamUK
- Department of Respiratory SciencesUniversity of LeicesterLeicesterUK
| | - Jonathan Chaloner
- Lifespan and Population Health Academic Unit, School of Medicine, Nottingham City HospitalUniversity of NottinghamNottinghamUK
- Department of Respiratory SciencesUniversity of LeicesterLeicesterUK
| | - Mayuri Gogoi
- Department of Respiratory SciencesUniversity of LeicesterLeicesterUK
| | - Irtiza Qureshi
- Lifespan and Population Health Academic Unit, School of Medicine, Nottingham City HospitalUniversity of NottinghamNottinghamUK
| | - Pankhuri Sahare
- Lifespan and Population Health Academic Unit, School of Medicine, Nottingham City HospitalUniversity of NottinghamNottinghamUK
| | - Manish Pareek
- Department of Respiratory SciencesUniversity of LeicesterLeicesterUK
| | - Kaushik Chattopadhyay
- Lifespan and Population Health Academic Unit, School of Medicine, Nottingham City HospitalUniversity of NottinghamNottinghamUK
| | - Laura B. Nellums
- Lifespan and Population Health Academic Unit, School of Medicine, Nottingham City HospitalUniversity of NottinghamNottinghamUK
- College of Population HealthUniversity of New MexicoAlbuquerqueNew MexicoUSA
| |
Collapse
|
5
|
Jablonka A, Dopfer C, Happle C, Shalabi A, Wetzke M, Hummers E, Friede T, Heinemann S, Hillermann N, Simmenroth A, Müller F. Acute respiratory infections in an adult refugee population: an observational study. NPJ Prim Care Respir Med 2021; 31:50. [PMID: 34934070 PMCID: PMC8692464 DOI: 10.1038/s41533-021-00261-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Accepted: 11/03/2021] [Indexed: 11/08/2022] Open
Abstract
The presence of acute infectious respiratory diseases (ARD) is one of the main reasons why recently arrived refugees seek medical help. This paper investigates the incidence rates of acute respiratory diseases in an adult refugee population as well as associated sociodemographic factors and drug treatments. We conducted a retrospective observational study of deidentified medical records. The data were collected between 2015 and 2019 in the health care centers of two large German initial reception centers for refugees. Multivariable analyses controlling for sociodemographics were carried out using generalized estimating equations. Out of 10,431 eligible residents, 6965 medical encounters of 2840 adult patients were recorded over 30 months. Of all the adult patients, 34.4% sought medical help for a respiratory symptom or diagnosis at least once. Older patients and patients from Sub-Saharan Africa sought help less often. The occurrence of ARD showed a typical distribution over the course of the year. Facility occupancy was not associated with ARD occurrence. Acute respiratory symptoms are a leading cause for adult refugee patients to seek medical care. The doctor contact rates due to ARD were consistently two to three times higher among refugees than among German residents.
Collapse
Affiliation(s)
- Alexandra Jablonka
- German Center for Infection Research (DZIF), Partner site Hannover-Braunschweig, Hannover, Germany
- Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
| | - Christian Dopfer
- Department of Pediatrics, Neonatology and Allergology, Hannover Medical School, Hannover, Germany
| | - Christine Happle
- Department of Pediatrics, Neonatology and Allergology, Hannover Medical School, Hannover, Germany
| | - Andree Shalabi
- Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
| | - Martin Wetzke
- German Center for Infection Research (DZIF), Partner site Hannover-Braunschweig, Hannover, Germany
- Department of Pediatrics, Neonatology and Allergology, Hannover Medical School, Hannover, Germany
| | - Eva Hummers
- Department of General Practice, University Medical Center Goettingen, Goettingen, Germany
| | - Tim Friede
- Department of Medical Statistics, University Medical Center Goettingen, Goettingen, Germany
| | - Stephanie Heinemann
- Department of General Practice, University Medical Center Goettingen, Goettingen, Germany
| | - Nele Hillermann
- Department of General Practice, University Medical Center Goettingen, Goettingen, Germany
| | - Anne Simmenroth
- Department of General Practice, University Medical Center Goettingen, Goettingen, Germany
- Department of General Practice, University Hospital Wuerzburg, Wuerzburg, Germany
| | - Frank Müller
- Department of General Practice, University Medical Center Goettingen, Goettingen, Germany.
| |
Collapse
|